Metacare introduces a **0.2mg dutasteride hair loss treatment**, marking its formal entry into the hair loss market. The company integrates **Metalabs’ medical and data expertise** to build an end-to-end ecosystem for hair loss solutions. This move combines Metacare’s product launch with its parent’s capabilities to address the full treatment lifecycle.
MetaCare acquires **JK Medi**, a distributor of medical consumables and equipment, to bolster its hospital **Management, Repair, and Operation (MRO)** business. The move integrates JK Medi’s distribution channels with MetaCare’s existing hospital networks, aiming to stabilize revenue and diversify its healthcare portfolio. The acquisition strengthens MetaCare’s position in the medical supply and equipment sector.
Metacare secures new AI medical business opportunities through its acquisition of a majority stake in TechLabs. The company’s asset value is now valued at 2.3 times its market capitalization, according to an analysis by ValueFinder. This undervaluation presents potential for future growth in medical data-driven ventures.
Metacare acquires majority control in Techlabs, an AI-driven adtech and digital healthcare firm. The move integrates Techlabs’ AI capabilities into Metacare’s hair loss medical services, enhancing precision diagnostics and personalized treatment through digital healthcare platforms. Techlabs specializes in AI-based solutions for healthcare and advertising technology, supporting Metacare’s expansion into data-driven medical innovations.
